Impact of graft size on postoperative thrombocytopenia in living donor liver transplant

Archives of Surgery

Volumn 142, Issue 11, 2007, Pages 1054-1058

  Marubashi, Shigeru ^a   Dono, Keizo ^a   Miyamoto, Atsushi ^a   Takeda, Yutaka ^a   Nagano, Hiroaki ^a   Umeshita, Koji ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; COTRIMOXAZOLE; GANCICLOVIR; INTERFERON; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT; LIVING DONOR; MALE; PORTAL VEIN BLOOD PRESSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; BLOOD PRESSURE; FEMALE; HEPATITIS C; HOSPITALS, UNIVERSITY; HUMANS; INTERFERONS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE; PORTAL VEIN; RETROSPECTIVE STUDIES; SPLENECTOMY; THROMBOCYTOPENIA; TRANSPLANTS;

EID: 36349033531     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.11.1054     Document Type: Article

References (23)

1. McCaughan GW, Herkes R, Powers B, et al. Thrombocytopenia post liver transplantation: correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol. 1992;16(1-2):16-22.
2. Ben Hamida C, Lauzet JY, Rezaiguia-Delclaux S, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med. 2003;29(5):756-762.
3. Shergill AK, Khalili M, Straley S, et al. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005;5(1):118-124.
4. Marcos A, Olzinski AT, Ham JM, Fisher RA, Posner MP. The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation. Transplantation. 2000;70(12):1697- 1703.
5. Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology. 2004;51(57):625-629.
6. Adinolfi LE, Giordano MG, Andreana A, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol. 2001;113(3):590-595.
7. Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol. 2000;95(10):2936-2939.
8. Sezai S, Kamisaka K, Ikegami F, et al. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol. 1998;93(1):80-82.
9. Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol. 2005;100(6):1311-1316.
10. Tsukahara A, Sato Y, Yamamoto S, et al. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Hepatogastroenterology. 2003;50(49):227-230.
11. Porte RJ, Blauw E, Knot EA, et al. Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol. 1994;21(4):592-600.
12. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996;24(2):135-140.
13. Pozzato C, Marzano L, Botta A, Anania RM, Uslenghi CM. Splenomegaly and hypersplenism in cirrhotic patients before and after orthotopic liver transplantation [in Italian]. Radiol Med (Torino). 1998;95(4):349-352.
14. Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75(8):1313-1317.
15. Marubashi S, Dono K, Nagano H, et al. Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts. Transplantation. 2005;80(12):1671-1675.
16. Schmid M, Kreil A, Jessner W, et al. Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut. 2005;54(7):1014-1020.
17. Cescon M, Sugawara Y, Takayama T, et al. Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology. 2002;49(45):721-723.
18. Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant. 2005;19(6):769-772.
19. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54(3):214-218.
20. Neumann UP, Langrehr JM, Kaisers U, Lang M, Schmitz V, Neuhaus P. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int. 2002;15(5):226-232.
21. Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237(3):429-436.
22. Matsukura A, Kita Y, Harihara Y, et al. Is splenic artery ligation effective for thrombocytopenia early after liver transplantation? Transplant Proc. 1999;31(7):2906-2907.
23. Sangro B, Bilbao I, Herrero I, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18(2):309-314.